To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min An Austin startup that has been ...
Following successful small-animal trials that confirmed bioequivalence, BioNxt is now taking the final preclinical step to prepare its sublingual Cladribine formulation for human testing. The upcoming ...
This is read by an automated voice. Please report any issues or inconsistencies here. I am living with ALS, or amyotrophic lateral sclerosis, often called Lou Gehrig’s disease. The average survival ...
Women living with and without HIV, age 30-65 years, were recruited in South Africa. Self-collected vaginal samples and clinician-collected cervical samples were tested with Xpert HPV, an assay that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results